Elevance Health, INC 10-Q quarterly reports

Elevance Health reports a 16.1% decrease in net income for Q2 2026 compared to the prior year, driven by increased medical costs and strategic investments, despite a slight rise in total operating revenue.

Elevance Health reported a 1.5% increase in total operating revenue for Q1 2026, reaching $49.5 billion, though net income saw a 19.2% decrease to $1.76 billion.

Elevance Health reported strong third-quarter revenue and EPS growth, yet nine-month net income and operating cash flow declined amidst rising medical costs and a significant litigation settlement.

Elevance Health reported a decrease in net income and diluted earnings per share for the second quarter and first half of 2025, primarily due to higher medical cost trends and increased financial instrument losses, despite significant operating revenue growth.

Elevance Health's Q1 2025 results show revenue growth driven by premium increases and strategic acquisitions, though net income saw a slight decrease.

Elevance Health's Q3 2024 results show a mix of revenue growth and profit challenges, influenced by Medicaid membership changes and strategic business adjustments.

Elevance Health's Q2 2024 results show a significant increase in net income and diluted earnings per share, driven by improved operating performance and strategic business activities.

Elevance Health's first quarter saw a slight revenue increase but was impacted by Medicaid membership attrition and changes in Medicare Star ratings.